Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections.
$1.06+12.09%
报价 2026-11-06
市值
$5.9M
EV
$-4.8M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -84.0%
$0.95$6.63
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ACXPAcurx Pharmaceuticals, Inc. | $5.9M | +12.1% | -97.1% | 0% | – | – | – | |
| BCDABioCardia, Inc. | $12.9M | -4.5% | 0.0% | 0% | – | – | – | |
| INABIN8bio, Inc. | $9.1M | +11.6% | +418.5% | 0% | – | – | – | |
| APREAprea Therapeutics, Inc. | $6.5M | +4.5% | +266.7% | 0% | – | – | – | |
| KPRXKiora Pharmaceuticals, Inc. | $6.4M | -4.0% | 0.0% | 0% | – | – | – | |
| APVOAptevo Therapeutics Inc. | $2.7M | -2.4% | +141.9% | 0% | – | – | – | |
| CELZCreative Medical Technology Holdings, Inc. | $1.6M | +2.6% | +1118724.9% | -1,732.4% | – | – | – | |
| HCWBHCW Biologics Inc. | $354,594 | -1.9% | -86.5% | 95.9% | – | – | – | |
| 同行中位数 | – | – | +141.9% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。